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Purpose: To examine the association between interpregnancy interval (IPI) and gestational diabetes
using both within-mother and between-mother comparisons.
Methods: A retrospective cohort studyof 103,909womenwhodelivered threeormore consecutive singleton
births (n ¼ 358,046) between 1 January 1980 and 31 December 2015 in Western Australia. The association
between IPI and gestational diabetes was estimated using conditional logistic regression, matching preg-
nancies to the same mother and adjusted for factors that vary within-mother across pregnancies. For com-
parisonwith previous studies, we also applied unmatched logistic regression (between-mother analysis).
Results: The conventional between-mother analysis resulted in adjusted odds ratios (aOR) of 1.13 (95% CI,
1.06e1.21) for intervals of 24e59 months and 1.51 (95% CI, 1.33e1.70) for intervals of 120 or more
months, compared with IPI of 18e23 months. In addition, short IPIs were associated with lower odds of
gestational diabetes with (aOR: 0.89; 95% CI, 0.82e0.97) for 6e11 months and (aOR: 0.92; 95% CI, 0.85
e0.99) for 12e17-month. In comparison, the adjusted within-mother matched analyses showed no
statistically significant association between IPIs and gestational diabetes. All effect estimates were
attenuated using the within-mother matched model.
Conclusion: Our findings do not support the hypothesis that short IPI (<6 months) increases the risk of
gestational diabetes and suggest that observed associations in previous research might be attributable to
confounders that vary between mothers.
© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
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Gestational diabetes is one of the major pregnancy complica-
tions that affect 6%e13% of pregnancies worldwide [1]. Pregnancies
complicated by gestational diabetes have an increased risk of
caesarean section, high blood pressure and greater risk of perinatal
complications including perinatal death [2e5].
The length of time between previous delivery and subsequent
conception (interpregnancy interval [IPI]) has been extensively
evaluatedwith respect to its associationwith birth outcomes [6e9].
However, there is relatively less research on its association with
pregnancy complications.
It has previously been observed that both short and long IPIs
increase the risk of gestational diabetes [10e14]. However, infer-
ence was limited due to small sample sizes, reliance on hospital-
based cohorts, insufficient control for important confounders
(e.g., socio-economic status [SES]) and biased IPI length measure-
ments, such as the use of birth-to-birth intervals or birth-to-
outcome intervals instead of birth to conception.
The World Health Organization (WHO) and the American Col-
lege of Obstetricians and Gynecologists recommend that women
shouldwait at least two years, and at least 18months after live birth
before commencing their next pregnancy, respectively [15,16].
However, the suitability of these recommendations for mothers in
high-income countries is uncertain as the recommendations
emanate from studies from low-income and middle-income set-
tings conducted prior to the early 2000's.
Several hypotheses have been postulated, including the
“maternal depletion” and “physiologic regression” hypotheses
[8,17,18]; however, a causal effect of IPI on pregnancy complications
has not yet been elucidated. Recently, researchers have posited that
the association between IPI and increased risk of adverse perinatal
outcomes might be attributed to confounding factors (“systematic
bias” hypothesis) [9,14,19]. It remains plausible that the previously
reported associations between IPI and gestational diabetes may be
explained by risk factors that tend to persist within-mothers across
pregnancies and potentially vary greatly between mothers [9,14].
Complementary within-mother matched analyses offer an oppor-
tunity to account for within-mother effects.
This study aimed to examine the association between IPI and
gestational diabetes employing both matched pregnancies within
the same mother and unmatched between-mother comparisons in
a high-income setting.
Materials and methods
Data source and study population
We conducted a retrospective cohort study using matched and
unmatched approaches to examine the association between IPI and
risk of gestational diabetes for all mothers who gave birth between
January 1st, 1980, and December 31st, 2015 in Western Australia
(WA). We sourced maternal, infant and birth information from the
Midwives Notification System (MNS), a population-wide registry of
all births (>99%) with at least 20 weeks’ gestation or with birth-
weight >400 grams if the gestational length is unknown [20].
Hospitalization records were identified from Hospital Morbidity
Data Collection (HMDC), which includes information on all hospi-
talizations in the state, with the Australian Modification of Inter-
national Classification of Diseases (ICD-10-AM) coded diagnostic
information and procedures performed [21]. Ethics approval was
obtained from the Human Research Ethics Committee (2016/51) of
the Department of Health, WA.
Our analyses included all mothers with at least three consecu-
tive singleton births (at least two IPIs) at 20e44 weeks of gestationin WA within the study period. Of the original total of 487,297
mothers who gave birth in the study period, we sequentially
excluded mothers who delivered multiples (n ¼ 4381); mothers
who delivered only once during the study period (n ¼ 189,269);
and mothers for whom parity as recorded in the birth record was
discordant with the order of the birth dates of her children
(n ¼ 5902). These exclusions resulted in a sample of 287,745
mothers with2 consecutive births eligible for analysis (Fig. 1). We
further excluded mothers who had missing information (e.g.,
gestational age, SES, maternal age, negative IPI) for one or more
pregnancies (n ¼ 7109). Finally, we excluded mothers with fewer
than two intervals (n¼ 176,727), leaving 103,909 mothers included
in the final analyses.
Measures
Outcome assessment
The outcome of interest, gestational diabetes was ascertained
from theMNSnotifications and hospital separation codes consistent
with gestational diabetes (ICD-9-AM: 648.8, ICD-10-AM: O24.4).
Exposure
The exposure, IPI, was defined as the length of time between
delivery date of the previous pregnancy and the estimated
conception date of the subsequent pregnancy (date of birth minus
gestational age at birth). Gestational age at birth was based on
dating ultrasounds, or last menstrual period when ultrasound was
not available. We used IPI as a categorical variable, grouped into
seven categories (<6 months, 6e11 months, 12e17 months,
18e23 months (reference), 24e59 months, 60e119 months, or 120
or more months), which is consistent withWHO recommendations
and categories used in past studies [9,14,22].
Independent variables
For the within-mother matched analyses, we adjusted for fac-
tors that can vary between births to the same mother. Specifically,
we adjusted for maternal age at time of each delivery (categorical
variable: 14e19, 20e24, 25e29, 30e34, 35e39, or 40 years or
older), parity, birth year (continuous), SES, infant sex, marital sta-
tus, history of obesity, known pre-existing hypertension and
gestational hypertension. SES was derived by the Australian Bureau
of Statistics as the Socio-Economic Index of Areas - Index of Relative
Socio-economic Disadvantage at a geographic area for the maternal
residence at the time of birth [23], which we categorized into
quintiles.
Statistical analysis
We summarized the socio-demographic and medical conditions
of the cohort at their first pregnancy during the study period. Con-
ditional logistic regression (accounting for matching pregnancies to
the samemother) was used to estimate odds of gestational diabetes
as a function of IPI categories, comparing pregnancies within-
mothers. Under this approach, effect estimates also controlled for
unmeasured characteristics that remained stable or strongly
correlated over time for mothers throughout their consecutive
pregnancies. This enables inference that is based purely on within-
mother effects [7,9,14]. To estimate the total effect of IPI, we
repeated our matched analyses without adjustment for maternal
age at time of each delivery and birth year. In the absence of residual
time-varying confoundingor selectionbias,wewouldexpect similar
effects of IPI on gestational diabetes in both between-mother and
within-mother comparisons. It is plausible that if unmeasured
persistent confounders exist, the unconditional logistic regression
may result in biased estimates [9]. For comparison with previous
unmatched studies, we also applied unmatched logistic regression
Eligible, singleton births
(n births=937,285)
(n mothers=482,916)
Eligible, >2 consecuƟve birth records per 
mother 
(n births=730,461)
(n mothers=287,745)
Excluded: gestaƟonal age null, <20 or >45 weeks
(n births=9,659)
(n mothers= 3,331)
Excluded: mothers aged<14 
(n births= 268)
(n mothers =69)
Excluded: all births to mothers with negaƟve IPI
(n births=80)
(n mothers=20)
Excluded: mothers with missing outcome
(n births=126)
(n mothers=39)
Excluded: mothers with undetermined sex of their 
child
(n births=26)
(n mothers=8)
Excluded: mothers with missing SES variable
(n births=8802)
(n mothers=3642)
Excluded: two birth record per mother
(n births=353,454)
(n mothers=176,727)
Excluded: inconsistent (non-consecuƟve) parity
(n births=17,555)
(n mothers=5,902)
Excluded: single birth record per mother
(n births=189,269)
(n mothers=189,269)
Excluded: mulƟple births
(n births=26,730)
(n mothers=4,381)
Eligible, >2 birth records per mother
(n births=748,016)
(n mothers= 293,647)
Total number of births in WA Midwives 
NoƟficaƟons System between 1980 and 2015
(n births=964,015)
(n mothers=487,297)
(n births= 358,046)
(n mothers= 103,909)
Fig. 1. Selection of eligible birth records included in this study e Western Australia, 1980e2015.
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tween mothers, such as race/ethnicity. To minimize multi-
collinearity between time-varying covariates (such as maternal age
at time of each delivery and birth year), ourwithin-mothermatched
model was adjusted for a prognostic score defined as the logit of the
probability of the outcome regressed on the adjustment variables
from an unmatched model. This results in estimation of the direct
effect of IPI and allows the whole cohort to contribute to the
adjustment for the underlying risk of the outcome [24].Supplementary analysis
We further estimated the association of gestational diabetes
with post-birth IPI. In the absence of confounding factors, gesta-
tional diabetes should not be associated with the IPI that follows
this birth. An observed association between gestational diabetes
and this post-birth IPI indicates the presence of factors in a mother
influencing both the risk of gestational diabetes and the IPI,
potentially leading to bias estimates. Thus, the post-birth IPI servesas a “negative control” exposure that estimates the effect of
mother-level confounding [19,25,26].Sensitivity analysis
To ascertain the sensitivity of our results to higher-order parity,
and inclusion of stillbirths, we conducted separate analyses
restricted to the first three births for all mothers with births at
parity 0,1, and 2, and tomothers with at least three consecutive live
births, respectively. To explore if our results are sensitive to the
time period of the cohort, we restricted our further analyses to
consecutive births after first of September 1997, after which
smoking status and pre-existing chronic conditions were routinely
recorded and ultrasound scans were more common (Appendix
Table 2, Model 2aec). Finally, we included a sensitivity analyses
restricted to mothers who had no gestational diabetes in their first
pregnancy, to ascertain if effect of IPI differs for those with and
without gestational diabetes in the first pregnancy (Appendix
Table 3).
Table 1
Socio-demographic characteristics and medical conditions of the study cohort of
mothers at their first birth included during the study period (n ¼ 103,909 mothers)
in Western Australia, 1980e2015
Characteristics Mothers, N (%)
Total number of mothers 103,909
Maternal age at first birth (y)
<25 56,901 (54.8)
25e29 32,988 (31.7)
30e34 12,467 (12.0)
35e39 1521 (1.5)
40 or older 32 (0.03)
Marital status
Married 83,875 (80.7)
Never married 19,221 (18.5)
Widowed, divorced, separated 618 (0.6)
Unknown 195 (0.2)
Race/ethnicity
Caucasian 88,106 (84.8)
Aboriginal/Torres Strait Islander 8267 (7.9)
Asian* 1986 (1.9)
African 600 (0.6)
Othersy 4950 (4.8)
Birth year
1980e1984 20,264 (19.5)
1985e1989 17,681 (17.0)
1990e1994 16,811 (16.2)
1995e1999 16,053 (15.4)
2000e2004 15,538 (15.0)
2005e2009 14,448 (13.9)
2010e2015 3114 (3.0)
SES in quintiles
<20th percentiles (most disadvantaged) 20,398 (19.6)
20e39th percentile 21,679 (20.8)
40e59th percentile 21,914 (21.1)
60e79th percentile 20,648 (19.9)
80th percentile (least disadvantaged) 19,270 (18.6)
Chronic conditions
Known chronic hypertension 259 (0.3)
Known chronic diabetes 181 (0.2)
Known obesity history 237 (0.2)
Pregnancy characteristics
Pregnancy complications
Gestational diabetes 1716 (1.6)
Gestational hypertension 2400 (2.3)
Infant sex
Male 54,132 (52.1)
Parity
0 96,314 (92.7)
1 4977 (4.8)
2 1636 (1.6)
3 374 (1.0)
* Including Indian.
y Including Polynesian & Maori.
Table 2
Characteristics of study population of births by gestational diabetes status for all
births to mothers with at least three consecutive births during the study period
(n ¼ 254,137 births) in Western Australia, 1980e2015
Characteristics Total Gestational diabetes
Births (N) Births, N (%)*
Total number of births 254,137 10,032 (4)
Interpregnancy interval (mo)
0e5 16,548 539 (3.3)
6e11 45,076 1261 (2.8)
12e17 50,528 1509 (3.0)
18e23 37,352 1272 (3.4)
24e59 78,909 3526 (4.5)
60e119 21,780 1499 (6.9)
120 or more 3944 426 (10.8)
Maternal age at time of each delivery (y)
<25 53,083 915 (1.7)
25e29 83,808 2430 (2.9)
30e34 77,280 3407 (4.4)
35e39 34,138 2603 (7.6)
40 or older 5828 677 (11.6)
Race/ethnicity
Caucasian 209,073 6803 (3.3)
Non-Caucasian 45,064 3229 (7.2)
Birth year
1980e1984 12,277 30 (0.3)
1985e1989 35,264 238 (0.7)
1990e1994 41,065 765 (1.9)
1995e1999 40,560 1353 (3.3)
2000e2004 39,082 1613 (4.1)
2005e2009 43,408 2098 (4.8)
2010e2015 42,481 3935 (9.3)
SES in quintiles
<20th percentiles (most disadvantaged) 51,221 2232 (4.4)
20e39th percentile 49,930 1915 (3.8)
40e59th percentile 49,689 1846 (3.7)
60e79th percentile 50,968 2027 (4.0)
80th percentile (least disadvantaged) 52,329 2012 (3.8)
Marital status
Married 229,549 8873 (3.8)
Never married 19,588 887 (4.5)
Widowed, divorced, separated 4156 225 (5.4)
Unknown 844 47 (5.6)
* Row percentages.
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Corporation, College Station, Texas). We reported unadjusted and
adjusted odds ratios (OR) and 95% confidence intervals (CIs) for
each model.Results
At study entry, defined as mothers’ first birth occurring during
the study period, the majority of women were generally free from
chronic hypertension, diabetes and obesity. There were 1716 (1.6%)
mothers who had a diagnosis of gestational diabetes at study entry
(Table 1). For all births included in the cohort, the incidence of
gestational diabetes during the study periodwas 4% (Table 2). There
were 16,548 (6%) births which occurred after an IPI of 0e5 months,
45,076 (18%) after 6e11 months, 50,528 (20%) after 12e17 months;
37,352 (15%), after 18e23 months; 78,909 (31%) after IPI of
24e59 months, 21,780 (9%) births after 60e119 months and 3944(1.6%) of births after 120 or more months. Gestational diabetes
diagnoses were more common among mothers in the older age
groups, and in mothers with longer IPIs (Table 2). Moreover,
mothers with shorter IPIs tended to be younger and non-Caucasian.
Observation of longer IPIs was more prevalent late in the study
period (1995 onwards) Appendix Table 1.
Compared to an IPI of 18e23 months, unmatched adjusted
analysis showed lower odds of gestational diabetes for 6e11-month
intervals (adjusted odds ratio (aOR), 0.89; 95% CI, 0.82e0.97) and
12e17-month intervals (aOR: 0.92; 95% CI, 0.85e0.99) (Table 3).
However, IPI of 24months ormorewas associatedwith greater odds
of gestational diabetes. Thegreatest adjustedeffectwas observed for
IPIs of 120 or more months (aOR: 1.51; 95% CI, 1.33e1.70).
Conditional logistic regression restricts analyses to births from
informative (non-concordant) strata (mothers), which in this study
were mothers who experienced gestational diabetes for at least
one, but not all of their births. There were 18,873 births to mothers
with non-concordant gestational diabetes. The unadjusted within-
mother matched comparison indicated that an IPI of 24 months or
longer was associated with greater odds of gestational diabetes
compared to an interval of 18e23 months, with OR ranging from
1.40 (95% CI, 1.26e1.55) for 24e59 months interval, to 3.65 (95% CI,
2.95e4.52) for IPI of 120 or more months. After full adjustment for
covariates including, maternal age at time of each delivery and
birth year, matched analyses showed a statistically non-significant
lower odd of gestational diabetes for short IPIs as compared to
Table 3
Odds Ratios (ORs) and 95% confidence intervals for the association between interpregnancy interval and gestational diabetes for births to mothers with at least three
consecutive births during the study period (n ¼ 103,909 mothers, n ¼ 254,137 births) in Western Australia, 1980e2015
IPI in months Unmatched Matched
Unadjusted OR (95% CI) Adjusted OR (95% CI)* Informative strata, n (%)x Unadjusted OR (95% CI) Adjusted OR (95% CI)y Adjusted OR (95% CI)z
0e5 0.95 (0.86e1.05) 1.01 (0.91e1.12) 1305 (6.9) 0.78 (0.67e0.91) 0.80 (0.68e0.95) 0.88 (0.75e1.05)
6e11 0.81 (0.75e0.88) 0.89 (0.82e0.97) 2954 (15.7) 0.79 (0.70e0.89) 0.84 (0.74e0.96) 0.92 (0.80e1.05)
12e17 0.87 (0.80e0.94) 0.92 (0.85e0.99) 3297 (17.5) 0.83 (0.74e0.93) 0.86 (0.76e0.98) 0.90 (0.79e1.02)
18e23 1.00 (reference) 1.00 (reference) 2489 (13.2) 1.00 (reference) 1.00 (reference) 1.00 (reference)
24e59 1.32 (1.24e1.41) 1.13 (1.06e1.21) 6096 (32.3) 1.40 (1.26e1.55) 1.29 (1.15e1.44) 1.07 (0.95e1.20)
60e119 2.09 (1.94e2.26) 1.32 (1.22e1.43) 2216 (11.7) 2.28 (2.01e2.57) 1.96 (1.71e2.23) 1.08 (0.93e1.25)
120 or more 3.42 (3.06e3.85) 1.51 (1.33e1.70) 516 (2.7) 3.65 (2.95e4.52) 3.02 (2.41e3.80) 1.02 (0.77e1.34)
Bold indicates statistical significance at the 5% level.
Models adjusted for the following variables.
* Maternal age at time of each delivery (categorical), parity, birth year, SES, race/ethnicity, marital status, infant sex, history of obesity, gestational hypertension and known
chronic hypertension.
y Prognostic score for gestational diabetes by parity, SES, marital status, infant sex, history of obesity, gestational hypertension, and known chronic hypertension.
z Prognostic score for gestational diabetes by maternal age at time of each delivery (categorical), birth year, parity, SES, marital status, infant sex, history of obesity,
gestational hypertension and known chronic hypertension.
x Number and percentage of informative strata of gestational diabetes for each IPI category for births to mothers with at least three consecutive births.
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0.75e1.05) for IPI lower than 6months and 0.90 (95% CI, 0.79e1.02)
for IPI of 12e17 months. However, we observed a statistically non-
significant increased odds of gestational diabetes for long IPI
compared to an 18e23-month IPI, with aORs ranging from 1.07
(95% CI, 0.95e1.20) for IPI of 24e59 months to 1.08 (95% CI,
0.93e1.25) for IPI of 60 months or longer.
The results of our sensitivity analyses Appendix Table 2
restricted to mothers with their first three consecutive births
[Model 2a], and a cohort that only included live births [Model 2b]
were consistent with the effect estimates obtained from our main
analyses. However, statistically significant lower odds of gestational
diabetes were observed for shorter IPIs of 0e5 months and
12e17 months in the model that excluded stillbirths [Model 2b].
Additionally, we observed a negligible difference in the association
between IPI and gestational diabetes whenwe restricted our cohort
to births from September 1997 onwards, for which more informa-
tion was available for adjustment, although this induced a 65%
reduction in sample size [Model 2c]. We observed a little difference
in the effect estimates with and without exclusion of mothers with
gestational diabetes in their first pregnancy Appendix Table 3. In
general, our sensitivity analyses collectively supported a weak
adverse association of long IPIs and gestational diabetes, similar to
those reported in the main analyses.
The adjusted model from the supplementary analyses indicated
that the short post-birth IPI of 6 months or less was statistically
significantly associated with gestational diabetes in the previous
pregnancy (aOR: 1.25; 95% CI, 1.03e1.52). However, the long post-
birth IPIs of 24 or more months were not associated with gesta-
tional diabetes in this model with aOR of 1.04 (95% CI, 0.91e1.18) for
post-birth IPI of 24e59 months and 1.18 (95% CI, 0.78e1.79) for 120
or more months (Appendix Table 4).
Discussion
Principal findings
Both the between-mother adjusted model and within-mother
unadjusted model indicate that IPIs of 24 months or longer were
associatedwith greater odds of gestational diabetes compared to an
interval of 18e23 months. In contrast, pregnancies that followed
IPIs shorter than 18e23 months had lower odds of gestational
diabetes. However, the fully adjusted within-mother matched an-
alyses showed no statistically significant association between short
and long IPIs and gestational diabetes.Meaning of the findings
Point estimates from within-mother analyses were lower than
those from between-mother analyses; and estimates from the
within-mother analyses were attenuated after full adjustment for
covariates, indicating that the influence of IPI could be partially
explained by the pathway through time-varying confounders, most
notably maternal age. Longer IPIs are inherently linked to
increasing maternal age, which is a well-established risk factor for
gestational diabetes [2,27]. Contrary to the findings of previous
between-mother comparisons [13,14], which showed that short
IPIs were statistically significantly associated with increased risk of
gestational diabetes, our results did not support the existence of an
adverse association between short IPIs and gestational diabetes.
This finding is consistent with previous unmatched cohort studies
[6,28] as well as recent case-control study [29]. However, our
findings for long IPIs are consistent with findings of other studies
[12,14,29].
The associations observed in the unmatched between-mother
comparisons were attenuated in the within-mother matched
comparisons. This suggests that the observed effects of short and
long IPIs in the unmatched between-mother comparison and pre-
vious similar unmatched studies likely were influenced by factors
that remain stable for mothers throughout their pregnancies (e.g.,
persistent lifestyle factors, SES) but vary much more between
women. Our long IPI findings are consistent with those from a
recent matched study of a Canadian cohort [14], which reported
that matched analyses resulted in statistically non-significant as-
sociations between long IPIs and gestational diabetes. However, our
findings differ for short IPIs, as the Canadian study reported greater
odds of gestational diabetes for short IPIs lower than 6 months. The
observed differences may be due to unmeasured confounding that
could arise from the lack of adjustment for known risk factors (SES,
parity) or differences in susceptibility of the study populations to
IPI in the Canadian study [14]. Future research would benefit from
exploring the role of pregnancy complications at mothers first
birth, as it remains possible that the effect of IPI might be modified
by gestational diabetes in first birth. In our cohort, there were 3906
total pregnancies among mothers who had gestational diabetes
during their first pregnancy, and 1525 (39%) pregnancies were
complicated by recurrent gestational diabetes.
Our supplementary analyses using post-birth IPI established the
presence of confounding of the association between IPI and
gestational diabetes by factors that vary between women
(Appendix Table 4). Specifically, short post-birth IPIs (<6 months)
A.T. Gebremedhin et al. / Annals of Epidemiology 39 (2019) 33e3838were associated with increased odds of gestational diabetes in the
previous pregnancy. Intuitively, a pregnancy complication cannot
be caused by an exposure that occurs after that complication. This
result provides justification for the within-mother design because
it demonstrates confounding at the mother-level [19,25]. The lack
of association between long post-birth IPI and gestational diabetes
might indicate that such confounding is less of a concern for longer
intervals.Strengths and limitations
We sourced our cohort from highly reliable population-based
perinatal information ascertained from hospital separations and
midwives’ notifications. To our knowledge this is the largest
population-based study to examine the association between IPIs
and gestational diabetes among mothers with at least three
consecutive births (two intervals) using within-mother comparison
(matching pregnancies of the same mother). The within-mother
matched design provides estimates based on a cohort of mothers
who have experienced pregnancies with and without the compli-
cation of interest (gestational diabetes). The premise of this design
is that it accounts to a larger extent for environmental and genetic
confounders that can vary between mothers.
There were some limitations to our study. Firstly, we restricted
our analyses to the outcomes of more than two births for each
mother to enable matching of at least two IPIs. Thus, although our
design achieves greater interval validity, there remains the possi-
bility of selection-bias. Secondly, we attempted to control time-
varying confounders but were unable to measure some variables
that may have significance (e.g., pre-pregnancy weight change).
However, matched analyses were statistically non-significant and
adjustment for such variables would have likely attenuated effect
estimates further, and our conclusions would have remained un-
changed. Thirdly, it should be acknowledged that chronic condi-
tions were not routinely collected until 1997 and without good
capture until 2000. However, our sensitivity analyses suggested
that the effect estimates were consistent between the main ana-
lyses, and births restricted to 1997 onwards with complete infor-
mation. Finally, as with all retrospective cohort studies that use
comprehensive perinatal records, we were unable to identify
pregnancy loss before 20 weeks of gestation. However, gestational
diabetes usually occurs later in pregnancy and if any bias is intro-
duced by truncation of pregnancies after 20 weeks of gestation, this
is likely to be limited to survivor bias. Even though, information on
pregnancy loss may be relevant to consider, findings from a recent
study reported insufficient evidence for differences in pregnancy
losses by IPI [30].
In conclusion, there was insufficient statistical evidence for a
harmful association between short IPI (<6 months) and gestational
diabetes in our cohort. Our findings do not support the hypothesis
that short IPI (<6months) increases risk of gestational diabetes and
suggests that observed associations in previous studies were
possibly attributable to residual confounding.Acknowledgments
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Characteristics of the study population of all births to mothers with at least three consecutive births during the study period (n ¼ 254,137 births) in Western Australia,
1980e2015
Characteristics Interpregnancy interval (months)
<6 6e11 12e17 18e23 24e59 60e119 120 or more
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Total (n ¼ 254,137) 16,548 (6.5) 45,076 (17.7) 50,528 (19.9) 37,352 (14.7) 78,909 (31.1) 21,780 (8.6) 3944 (1.6)
Gestational diabetes (GDM), n (%): 10,032 (4)
Yes 539 (3.3) 1261 (2.8) 1509 (3.0) 1272 (3.4) 3526 (4.5) 1499 (6.9) 426 (10.8)
Maternal age at time of each delivery (y)
<25 6656 (40.2) 13,032 (28.9) 11,872 (23.5) 7747 (20.7) 12,871 (16.3) 905 (4.2) 0 (0.0)
25e29 5395 (32.6) 15,905 (35.3) 17,822 (35.3) 13,023 (34.9) 25,743 (32.6) 5733 (26.3) 187 (4.7)
30e34 3220 (19.5) 11,627 (25.8) 14,883 (29.5) 11,610 (31.1) 26,394 (33.5) 8378 (38.5) 1168 (29.6)
35e39 1130 (6.8) 4024 (8.9) 5290 (10.5) 4397 (11.8) 12,040 (15.3) 5528 (25.4) 1729 (43.8)
40 or older 147 (0.9) 488 (1.1) 661 (1.3) 575 (1.5) 1861 (2.4) 1236 (5.7) 860 (21.8)
Marital status
Married 14,263 (86.2) 41,118 (91.2) 46,825 (92.7) 34,438 (92.2) 70,892 (89.8) 18,705 (85.9) 3308 (83.9)
Never married 1948 (11.8) 3303 (7.3) 3074 (6.1) 2382 (6.4) 6312 (8.0) 2178 (10.0) 391 (9.9)
Widowed, divorced,
separated
282 (1.7) 545 (1.2) 497 (1.0) 419 (1.1) 1429 (1.8) 772 (3.5) 212 (5.4)
Unknown 55 (0.3) 110 (0.2) 132 (0.3) 113 (0.3) 276 (0.4) 125 (0.6) 33 (0.8)
Race/ethnicity
Caucasian 12,299 (74.3) 37,050 (82.2) 42,262 (83.6) 31,413 (84.1) 64,944 (82.3) 17,801 (81.7) 3304 (83.8)
Non-Caucasian 4249 (25.7) 8026 (17.8) 8266 (16.4) 5939 (15.9) 13,965 (17.7) 3979 (18.3) 640 (16.2)
Birth year
1980e1984 1452 (8.8) 3698 (8.2) 3545 (7.0) 1973 (5.3) 1609 (2.0) 0 (0.0) 0 (0.0)
1985e1989 2460 (14.9) 7173 (15.9) 8132 (16.1) 5862 (15.7) 10,641 (13.5) 996 (4.6) 0 (0.0)
1990e1994 2569 (15.5) 7315 (16.2) 8381 (16.6) 6260 (16.8) 13,059 (16.6) 3275 (15.0) 206 (5.2)
1995e1999 2433 (14.7) 6807 (15.1) 7725 (15.3) 5787 (15.5) 13,192 (16.7) 3931 (18.1) 685 (17.4)
2000e2004 2327 (14.1) 6367 (14.1) 7201 (14.3) 5545 (14.9) 12,652 (16.0) 4125 (18.9) 865 (21.9)
2005e2009 2828 (17.1) 7398 (16.4) 8023 (15.9) 5943 (15.9) 13,443 (17.0) 4686 (21.5) 1087 (27.6)
2010e2015 2479 (15.0) 6318 (14.0) 7521 (14.9) 5982 (16.0) 14,313 (18.1) 4767 (21.9) 1101 (27.9)
SES*
1 4602 (27.8) 9386 (20.8) 9482 (18.8) 6905 (18.5) 15,507 (19.7) 4603 (21.1) 736 (18.7)
2 3712 (22.4) 9070 (20.1) 9563 (18.9) 7096 (19.0) 15,245 (19.3) 4445 (20.4) 799 (20.3)
3 3283 (19.8) 8994 (20.0) 9909 (19.6) 7367 (19.7) 15,073 (19.1) 4276 (19.6) 787 (20.0)
4 2749 (16.6) 8938 (19.8) 10,450 (20.7) 7684 (20.6) 15,976 (20.3) 4328 (19.9) 843 (21.4)
5 2202 (13.3) 8688 (19.3) 11,124 (22.0) 8300 (22.2) 17,108 (21.7) 4128 (19.0) 779 (19.8)
* Categorized as quintiles (1 ¼ most disadvantaged to 5 ¼ least disadvantaged).
Appendix Table 2
Odds Ratios (OR) and 95% confidence intervals for the association between interpregnancy interval and gestational diabetes for births to (Model 2a) mothers with three
consecutive births (parity 0,1, 2); (Model 2b)motherswith at least three consecutive live births; (Model 2c) mothers with at least three consecutive births during the end of the
study period (Sept 1997 onwards) in Western Australia, 1980e2015
IPI in months Unmatched Matched
Unadjusted OR (95% CI) Adjusted OR (95% CI)* Unadjusted OR (95% CI) Adjusted OR (95% CI)y Adjusted OR (95% CI)z
Gestational diabetes
Model 2a: (n ¼ 96,354 mothers, n ¼ 192,708 births)
0e5 0.99 (0.87e1.12) 1.14 (1.00e1.30) 0.82 (0.66e1.03 0.83 (0.66e1.05) 0.94 (0.75e1.19)
6e11 0.86 (0.78e0.95) 0.97 (0.87e1.07) 0.89 (0.75e1.05) 0.93 (0.78e1.11) 1.01 (0.84e1.20)
12e17 0.88 (0.79e0.96) 0.94 (0.85e1.03) 0.82 (0.70e0.96) 0.86 (0.73e1.01) 0.91 (0.76e1.07)
18e23 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
24e59 1.34 (1.24e1.45) 1.14 (1.05e1.24) 1.44 (1.25e1.65) 1.37 (1.18e1.58) 1.11 (0.95e1.29)
60e119 2.16 (1.97e2.38) 1.36 (1.23e1.50) 2.42 (2.03e2.88) 2.22 (1.85e2.66) 1.19 (0.97e1.45)
120 or more 3.82 (3.32e4.38) 1.60 (1.38e1.86) 3.13 (2.39e4.10) 2.72 (2.06e3.59) 0.92 (0.65e1.30)
Model 2b: (n ¼ 100,286 mothers, n ¼ 244,125 births)
0e5 0.90 (0.81e1.01) 0.96 (0.86e1.07) 0.74 (0.63e0.88) 0.75 (0.62e0.90) 0.82 (0.68e0.98)
6e11 0.80 (0.74e0.87) 0.88 (0.81e0.96) 0.75 (0.66e0.85) 0.82 (0.71e0.94) 0.87 (0.76e1.01)
12e17 0.85 (0.79e0.92) 0.91 (0.83e0.98) 0.79 (0.70e0.89) 0.83 (0.73e0.95) 0.86 (0.76e0.99)
18e23 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
24e59 1.33 (1.25e1.42) 1.14 (1.07e1.22) 1.40 (1.26e1.55) 1.28 (1.14e1.43) 1.10 (0.97e1.23)
60e119 2.11 (1.95e2.29) 1.34 (1.23e1.45) 2.26 (1.99e2.56) 1.90 (1.65e2.18) 1.13 (0.97e1.31)
120 or more 3.45 (3.08e3.88) 1.52 (1.34e1.72) 3.66 (2.93e4.56) 2.95 (2.32e3.73) 1.13 (0.86e1.50)
Model 2c: (n ¼ 40,405 mothers, n ¼ 93,716 births)
0e5 0.91 (0.79e1.04) 1.05 (0.91e1.21) 0.77 (0.62e0.95) 0.83 (0.66e1.04) 0.91 (0.72e1.15)
6e11 0.82 (0.74e0.91) 0.93 (0.84e1.03) 0.74 (0.63e0.87) 0.84 (0.70e1.00) 0.90 (0.75e1.07)
12e17 0.91 (0.82e1.01) 0.97 (0.88e1.07) 0.79 (0.67e0.92) 0.89 (0.75e1.06) 0.92 (0.77e1.09)
18e23 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
24e59 1.32 (1.20e1.44) 1.15 (1.07e1.27) 1.41 (1.22e1.62) 1.32 (1.13e1.54) 1.07 (0.91e1.25)
60e119 2.01 (1.80e2.25) 1.33 (1.19e1.49) 2.18 (1.81e2.63) 2.05 (1.67e2.51) 1.05 (0.84e1.31)
120 or more 2.78 (2.07e3.74) 1.28 (0.95e1.74) 1.94 (1.16e3.26) 2.03 (1.16e3.55) 0.61 (0.30e1.24)
Bold indicates significance at the 5% level.
Model 2a and 2b were adjusted for the following variables.
* Maternal age at time of each delivery (categorical), birth year, parity, SES, race/ethnicity, marital status, infant sex, history of obesity; gestational hypertension and known
chronic hypertension.
y Prognostic score for GDM of parity, SES, marital status, infant sex, history of obesity; gestational hypertension, and known chronic hypertension.
z Prognostic score for GDMofmaternal age at time of each delivery (categorical), parity, birth year, SES, marital status, infant sex, history of obesity; gestational hypertension
and known chronic hypertension; Model 2c: includes all variables in Model 2a plus smoking during pregnancy.
Appendix Table 3
Odds Ratios (OR) and 95% confidence intervals for the association between interpregnancy interval and gestational diabetes for births to (Model-A) mothers with at least three
consecutive births during the study period (n ¼ 103,909 mothers, n ¼ 254,137 births); (Model-B) mothers with at least three consecutive births during the study period,
excluding mothers with gestational diabetes in first pregnancy (n ¼ 102,193 mothers, n ¼ 250,231 births) in Western Australia, 1980e2015
IPI in months Unmatched
Unadjusted OR (95% CI) Adjusted OR (95% CI)*
Model A Model B Model A Model B
0e5 0.95 (0.86e1.05) 0.97 (0.86e1.08) 1.01 (0.91e1.12) 1.00 (0.89e1.13)
6e11 0.81 (0.75e0.88) 0.79 (0.72e0.87) 0.89 (0.82e0.97) 0.86 (0.79e0.95)
12e17 0.87 (0.80e0.94) 0.84 (0.77e0.91) 0.92 (0.85e0.99) 0.88 (0.81e0.96)
18e23 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
24e59 1.32 (1.24e1.41) 1.42 (1.32e1.52) 1.13 (1.06e1.21) 1.21 (1.13e1.30)
60e119 2.09 (1.94e2.26) 2.40 (2.21e2.61) 1.32 (1.22e1.43) 1.52 (1.40e1.66)
120 3.42 (3.06e3.85) 4.07 (3.61e4.58) 1.51 (1.33e1.70) 1.83 (1.61e2.08)
IPI in months Matched
Informative strata, n (%)x Unadjusted OR (95% CI) Adjusted OR (95% CI)y Adjusted OR (95% CI)z
Model A Model B Model A Model B Model A Model B Model A Model B
0e5 1305 (6.9) 1202 (6.9) 0.78 (0.67e0.91) 0.77 (0.65e0.91) 0.80 (0.68e0.95) 0.79 (0.67e0.95) 0.88 (0.75e1.05) 0.87 (0.73e1.05)
6e11 2954 (15.7) 2665 (15.3) 0.79 (0.70e0.89) 0.79 (0.70e0.89) 0.84 (0.74e0.96) 0.84 (0.73e0.96) 0.92 (0.80e1.05) 0.91 (0.79e1.05)
12e17 3297 (17.5) 3004 (17.2) 0.83 (0.74e0.93) 0.82 (0.72e0.93) 0.86 (0.76e0.98) 0.84 (0.74e0.96) 0.90 (0.79e1.02) 0.87 (0.76e1.00)
18e23 2489 (13.2) 2262 (12.9) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
24e59 6096 (32.3) 5685 (32.6) 1.40 (1.26e1.55) 1.43 (1.29e1.60) 1.29 (1.15e1.44) 1.33 (1.19e1.50) 1.07 (0.95e1.20) 1.10 (0.97e1.24)
60e119 2216 (11.7) 2128 (12.2) 2.28 (2.01e2.57) 2.37 (2.08e2.69) 1.96 (1.71e2.23) 2.04 (1.77e2.34) 1.08 (0.93e1.25) 1.11 (0.95e1.29)
120 516 (2.7) 504 (2.9) 3.65 (2.95e4.52) 3.75 (3.02e4.67) 3.02 (2.41e3.80) 3.07 (2.43e3.88) 1.02 (0.77e1.34) 1.01 (0.75e1.34)
Bold indicates significance at the 95% confidence level.
Models adjusted for the following variables.
* Maternal age at time of each delivery (categorical), parity, birth year, SES, race/ethnicity, marital status, infant sex, history of obesity, gestational hypertension and known
chronic hypertension.
y Prognostic score for gestational diabetes by parity, SES, marital status, infant sex, history of obesity, gestational hypertension, and known chronic hypertension.
z Prognostic score for gestational diabetes by maternal age at time of each delivery (categorical), birth year, parity, SES, marital status, infant sex, history of obesity,
gestational hypertension and known chronic hypertension.
x Number and percentage of informative strata of gestational diabetes for each IPI category for births to mothers with at least three consecutive births.
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Appendix Table 4
Odds Ratios (ORs) and 95% confidence intervals for the association between post-
birth interpregnancy interval (interval between second and third births) and
gestational diabetes in the second birth for mothers with three consecutive births
during the study period (n ¼ 96,354 births) in Western Australia, 1980e2015
IPI in months Unadjusted OR (95% CI) Adjusted OR (95% CI)y
Gestational diabetes*
0e5 1.36 (1.13e1.65) 1.25 (1.03e1.52)
6e11 1.00 (0.86e1.16) 0.94 (0.81e1.10)
12e17 1.05 (0.91e1.22) 1.02 (0.88e1.18)
18e23 1.00 (reference) 1.00 (reference)
24e59 0.93 (0.82e1.06) 1.04 (0.91e1.18)
60e119 0.67 (0.55e0.81) 0.96 (0.79e1.16)
120 or more 0.54 (0.36e0.81) 1.18 (0.78e1.79)
* Predicting gestational diabetes of second born (parity 1 births) using post-
pregnancy IPI (interval between second born and third born births).
y Model adjusted for maternal age (categorical), birth year, parity, SES, race/
ethnicity, marital status, infant sex, history of obesity, gestational hypertension and
known chronic hypertension.
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